Ocean Quest

Ocean Biomedical is a biopharmaceutical company focused on accelerating the development of high-impact discoveries from top-tier research universities and medical centers. The company operates through a unique business model that bridges the gap between academic research and commercial drug development, primarily focusing on oncology, fibrosis, and infectious diseases. Their lead programs include a first-in-class immunotherapy targeting CHI3L1 for multiple solid tumors and a novel malaria vaccine candidate. By leveraging established scientific breakthroughs, Ocean Biomedical aims to deliver transformative therapies for significant unmet medical needs.